IBEX Technologies Inc V.IBT

Ibex Peer Group Comparison

[guarantor1]

From the 2022 Ibex Management Proxy Circular :

0. Peer Group

   A comparison of remuneration with similar companies in the pharmaceutical industry (the “Peer Group”) was performed during 2020 by the Compensation Committee. The Peer Group was composed of the following companies:

- Antibe Therapeutics Inc.
- Kane Biotech Inc.
- Nuvo Pharmaceuticals Inc. - Relevium Technologies Inc.

- Pascal Biosciences Inc.
- Replicel Life Sciences Inc. - Revive Therapeutics Ltd.

What's really interesting in my opinion, is that Ibex is the only company with Positive Earnings. 
Based on 2021 earnings of .05 cents @ share, IBT's P/E = 9.7.
Market Cap =$11.5M, compared to ATE $35M // KNE $17M //MRV $16M // RVV $97M,
and RLV, PAS, RP have lower Cap's

 

[nozzpack]

Thank you. Once again, we see how brutally undervalued Ibex really is. With a strong outlook  for continued growth in sales and earnings and their options just set at $0.49, It's like shooting dead fish in a barrel..